{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T11:59:58Z","timestamp":1791115198107,"version":"4.1.0"},"reference-count":14,"publisher":"American Society for Microbiology","issue":"8","license":[{"start":{"date-parts":[[2003,8,1]],"date-time":"2003-08-01T00:00:00Z","timestamp":1059696000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.asm.org\/non-commercial-tdm-license"}],"content-domain":{"domain":["journals.asm.org"],"crossmark-restriction":true},"short-container-title":["Antimicrob Agents Chemother"],"published-print":{"date-parts":[[2003,8]]},"abstract":"<jats:title>ABSTRACT<\/jats:title><jats:p>Human leptospirosis is generally treated with penicillin or doxycycline. We studied the susceptibilities of 11 serovars (seven species) of<jats:italic>Leptospira<\/jats:italic>to 14 antibiotics. With the exception of chloramphenicol, all tested agents were at least as potent as penicillin and doxycycline, with the macrolide and ketolide drugs producing the lowest MICs (and minimal bactericidal concentrations).<\/jats:p>","DOI":"10.1128\/aac.47.8.2646-2648.2003","type":"journal-article","created":{"date-parts":[[2003,7,23]],"date-time":"2003-07-23T19:24:32Z","timestamp":1058988272000},"page":"2646-2648","update-policy":"https:\/\/doi.org\/10.1128\/asmj-crossmark-policy-page","source":"Crossref","is-referenced-by-count":54,"title":["In Vitro Susceptibilities of Seven<i>Leptospira<\/i>Species to Traditional and Newer Antibiotics"],"prefix":"10.1128","volume":"47","author":[{"given":"Duane R.","family":"Hospenthal","sequence":"first","affiliation":[{"name":"Infectious Disease Service, Department of Medicine, Brooke Army Medical Center, Fort Sam Houston, Texas"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clinton K.","family":"Murray","sequence":"additional","affiliation":[{"name":"Infectious Disease Service, Department of Medicine, Brooke Army Medical Center, Fort Sam Houston, Texas"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"235","reference":[{"key":"e_1_3_2_2_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.30.6.835"},{"key":"e_1_3_2_3_2","doi-asserted-by":"crossref","first-page":"59","DOI":"10.2460\/ajvr.1996.57.01.59","volume":"57","year":"1996","unstructured":"Alt, D. P., and C. A. Bolin. 1996. Preliminary evaluation of antimicrobial agents for treatment of Leptospira interrogans serovar pomona infection in hamsters and swine. Am. J. Vet. Res.57:59-62.","journal-title":"Am. J. Vet. Res."},{"key":"e_1_3_2_4_2","first-page":"425","volume":"261","year":"1986","unstructured":"Broughton, E. S., and L. E. Flack. 1986. The susceptibility of a strain of Leptospira interrogans serogroup icterohaemorrhagiae to amoxycillin, erythromycin, lincomycin, tetracycline, oxytetracycline and minocycline. Zentralbl. Bakteriol. Mikrobiol. Hyg. A261:425-431.","journal-title":"Zentralbl. Bakteriol. Mikrobiol. Hyg. A"},{"key":"e_1_3_2_5_2","doi-asserted-by":"publisher","DOI":"10.4269\/ajtmh.1988.39.388"},{"key":"e_1_3_2_6_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(99)80012-9"},{"key":"e_1_3_2_7_2","doi-asserted-by":"publisher","DOI":"10.1128\/CMR.14.2.296-326.2001"},{"key":"e_1_3_2_8_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-100-5-696"},{"key":"e_1_3_2_9_2","first-page":"193","volume":"24","year":"2001","unstructured":"Murgia, R., and M. Cinco. 2001. Sensitivity of Borrelia and Leptospira to quinupristin-dalfopristin (Synercid)\u00ae in vitro. New Microbiol.24:193-196.","journal-title":"New Microbiol."},{"key":"e_1_3_2_10_2","unstructured":"NCCLS. 1997. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically 4th ed. Approved standard. NCCLS document M7-A4. NCCLS Wayne Pa."},{"key":"e_1_3_2_11_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.24.6.905"},{"key":"e_1_3_2_12_2","first-page":"7","volume":"81","year":"1991","unstructured":"Prescott, J. 1991. Treatment of leptospirosis. Cornell Vet.81:7-12.","journal-title":"Cornell Vet."},{"key":"e_1_3_2_13_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.33.5.788"},{"key":"e_1_3_2_14_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.37.4.901"},{"key":"e_1_3_2_15_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(88)91230-5"}],"container-title":["Antimicrobial Agents and Chemotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/AAC.47.8.2646-2648.2003","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/AAC.47.8.2646-2648.2003","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,13]],"date-time":"2024-12-13T07:54:12Z","timestamp":1734076452000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.asm.org\/doi\/10.1128\/AAC.47.8.2646-2648.2003"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,8]]},"references-count":14,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2003,8]]}},"alternative-id":["10.1128\/AAC.47.8.2646-2648.2003"],"URL":"https:\/\/doi.org\/10.1128\/aac.47.8.2646-2648.2003","relation":{},"ISSN":["0066-4804","1098-6596"],"issn-type":[{"value":"0066-4804","type":"print"},{"value":"1098-6596","type":"electronic"}],"subject":[],"published":{"date-parts":[[2003,8]]},"assertion":[{"value":"2002-12-26","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2003-05-12","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2003-08-01","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}